Results
|
|
81.
|
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment. [electronic resource] by
- Devriese, L A
- Witteveen, P O
- Marchetti, S
- Mergui-Roelvink, M
- Reyderman, L
- Wanders, J
- Jenner, A
- Edwards, G
- Beijnen, J H
- Voest, E E
- Schellens, J H M
Producer: 20130124
In:
Cancer chemotherapy and pharmacology vol. 70
Availability: No items available.
|
|
|
82.
|
Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases. [electronic resource] by
- Brandsma, D
- Taphoorn, M J B
- de Jager, W
- Bonfrer, H
- Algra, A
- Reijneveld, J C
- Boogerd, W
- Korse, T
- Verbeek, M M
- Rijkers, G T
- Voest, E E
Producer: 20060314
In:
Neurology vol. 66
Availability: No items available.
|
|
|
83.
|
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. [electronic resource] by
- Kuroki, M
- Voest, E E
- Amano, S
- Beerepoot, L V
- Takashima, S
- Tolentino, M
- Kim, R Y
- Rohan, R M
- Colby, K A
- Yeo, K T
- Adamis, A P
Producer: 19961119
In:
The Journal of clinical investigation vol. 98
Availability: No items available.
|
|
|
84.
|
|
|
|
85.
|
A phase 1 comparative pharmacokinetic and cardiac safety study of two intravenous formulations of CO-101 in patients with advanced solid tumors. [electronic resource] by
- Stuurman, F E
- Lolkema, M P
- Huitema, A D R
- Soetekouw, P M M B
- Rosing, H
- Rolfe, L
- Kaur, P
- Beijnen, J H
- van Tinteren, H
- Voest, E E
- Schellens, J H M
Producer: 20140320
In:
Journal of clinical pharmacology vol. 53
Availability: No items available.
|
|
|
86.
|
Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. [electronic resource] by
- Giles, R H
- Lolkema, M P
- Snijckers, C M
- Belderbos, M
- van der Groep, P
- Mans, D A
- van Beest, M
- van Noort, M
- Goldschmeding, R
- van Diest, P J
- Clevers, H
- Voest, E E
Producer: 20060707
In:
Oncogene vol. 25
Availability: No items available.
|
|
|
87.
|
Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks. [electronic resource] by
- Kerbusch, T
- Groenewegen, G
- Mathôt, R A A
- Herben, V M M
- ten Bokkel Huinink, W W
- Swart, M
- Ambaum, B
- Rosing, H
- Jansen, S
- Voest, E E
- Beijnen, J H
- Schellens, J H M
Producer: 20040713
In:
British journal of cancer vol. 90
Availability: No items available.
|
|
|
88.
|
Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors. [electronic resource] by
- Oostendorp, R L
- Loftiss, J
- Goel, S
- Smith, D A
- Dar, M M
- Witteveen, P O
- Cohen, R B
- Lewis, L D
- Kurian, S
- Patnaik, A
- Rosing, H
- Beijnen, J H
- Voest, E E
- Burris, H
Producer: 20090511
In:
International journal of clinical pharmacology and therapeutics vol. 47
Availability: No items available.
|
|
|
89.
|
Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors. [electronic resource] by
- Langenberg, M H G
- Witteveen, P O
- Roodhart, J
- Lolkema, M P
- Verheul, H M W
- Mergui-Roelvink, M
- Brendel, E
- Krätzschmar, J
- Loembé, B
- Nol-Boekel, A
- Christensen, O
- Schellens, J H M
- Voest, E E
Producer: 20111219
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
|
90.
|
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study. [electronic resource] by
- Snoeren, Nikol
- van Hillegersberg, Richard
- Schouten, Sander B
- Bergman, Andre M
- van Werkhoven, Erikv
- Dalesio, Otilia
- Tollenaar, Rob A E M
- Verheul, Henk M
- van der Sijp, Joost
- Borel Rinkes, Inne H M
- Voest, E E
Producer: 20170504
In:
Neoplasia (New York, N.Y.) vol. 19
Availability: No items available.
|
|
|
91.
|
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer. [electronic resource] by
- Rodenhuis, S
- Bontenbal, M
- van Hoesel, Q G C M
- Smit, W M
- Nooij, M A
- Voest, E E
- van der Wall, E
- Hupperets, P
- van Tinteren, H
- Peterse, J L
- van de Vijver, M J
- de Vries, E G E
Producer: 20060927
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 17
Availability: No items available.
|
|
|
92.
|
Molecular Tumor Boards: current practice and future needs. [electronic resource] by
- van der Velden, D L
- van Herpen, C M L
- van Laarhoven, H W M
- Smit, E F
- Groen, H J M
- Willems, S M
- Nederlof, P M
- Langenberg, M H G
- Cuppen, E
- Sleijfer, S
- Steeghs, N
- Voest, E E
Producer: 20180502
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
93.
|
Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape. [electronic resource] by
- Vis, D J
- Lewin, J
- Liao, R G
- Mao, M
- Andre, F
- Ward, R L
- Calvo, F
- Teh, B T
- Camargo, A A
- Knoppers, B M
- Sawyers, C L
- Wessels, L F A
- Lawler, M
- Siu, L L
- Voest, E
Producer: 20180302
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
94.
|
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin. [electronic resource] by
- Ploquin, A
- Olmos, D
- Lacombe, D
- A'Hern, R
- Duhamel, A
- Twelves, C
- Marsoni, S
- Morales-Barrera, R
- Soria, J-C
- Verweij, J
- Voest, E E
- Schöffski, P
- Schellens, J H
- Kramar, A
- Kristeleit, R S
- Arkenau, H-T
- Kaye, S B
- Penel, N
Producer: 20130307
In:
British journal of cancer vol. 107
Availability: No items available.
|
|
|
95.
|
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database. [electronic resource] by
- Cassier, P A
- Polivka, V
- Judson, I
- Soria, J-C
- Penel, N
- Marsoni, S
- Verweij, J
- Schellens, J H
- Morales-Barrera, R
- Schöffski, P
- Voest, E E
- Gomez-Roca, C
- Evans, T R J
- Plummer, R
- Gallerani, E
- Kaye, S B
- Olmos, D
Producer: 20150121
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
|
96.
|
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models. [electronic resource] by
- Vermaat, J S
- van der Tweel, I
- Mehra, N
- Sleijfer, S
- Haanen, J B
- Roodhart, J M
- Engwegen, J Y
- Korse, C M
- Langenberg, M H
- Kruit, W
- Groenewegen, G
- Giles, R H
- Schellens, J H
- Beijnen, J H
- Voest, E E
Producer: 20100930
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 21
Availability: No items available.
|
|
|
97.
|
Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma. [electronic resource] by
- van der Sluis, P C
- Ubink, I
- van der Horst, S
- Boonstra, J J
- Voest, E E
- Ruurda, J P
- Borel Rinkes, I H M
- Wiezer, M J
- Schipper, M E I
- Siersema, P D
- Los, M
- Lolkema, M P
- van Hillegersberg, R
Producer: 20160112
In:
Annals of surgical oncology vol. 22
Availability: No items available.
|
|
|
98.
|
Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy. [electronic resource] by
- Hannemann, J
- Kristel, P
- van Tinteren, H
- Bontenbal, M
- van Hoesel, Q G C M
- Smit, W M
- Nooij, M A
- Voest, E E
- van der Wall, E
- Hupperets, P
- de Vries, E G E
- Rodenhuis, S
- van de Vijver, M J
Producer: 20070116
In:
British journal of cancer vol. 95
Availability: No items available.
|
|
|
99.
|
Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients. [electronic resource] by
- Nieboer, P
- de Vries, E G E
- Mulder, N H
- Rodenhuis, S
- Bontenbal, M
- van der Wall, E
- van Hoesel, Q G
- Smit, W M
- Hupperets, P
- Voest, E E
- Nooij, M A
- Boezen, H M
- van der Graaf, W T A
Producer: 20081231
In:
Bone marrow transplantation vol. 42
Availability: No items available.
|
|
|
100.
|
[Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus]. [electronic resource] by
- de Mulder, P H M
- Haanen, J B A G
- Sleijfer, S
- Kruit, W H J
- Gietema, J A
- Richel, D J
- Groenewegen, G
- Voest, E E
- van den Eertwegh, A J M
- Osanto, S
- Jansen, R L H
- Mulders, P F A
Producer: 20080428
In:
Nederlands tijdschrift voor geneeskunde vol. 152
Availability: No items available.
|